Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.62 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.62 |
| ▸ | NOD1 | Q9Y239 | 11/20 | 0.55 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.46 |
| ▸ | FNTA | P49354 | 2/20 | 0.45 |
| ▸ | FNTB | P49356 | 2/20 | 0.45 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.45 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.43 |
| ▸ | GNPAT | O15228 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL523606 | 1.00 | PTGS1 (0.62) | PTGS1GSTK1NOD1FOLH1FNTA | |
| SCHEMBL1171265 | 0.96 | PTGS1 (0.61) | PTGS1GSTK1NOD1FOLH1FNTA | |
| SCHEMBL9160515 | 0.96 | PTGS1 (0.61) | PTGS1GSTK1NOD1FOLH1FNTA | |
| SCHEMBL12867524 | 0.96 | PTGS1 (0.61) | PTGS1GSTK1NOD1FOLH1FNTA | |
| SCHEMBL12809515 | 0.90 | PTGS1 (0.62) | PTGS1GSTK1NOD1FOLH1FNTA | |
| SCHEMBL929035 | 0.89 | PTGS1 (0.72) | PTGS1GSTK1NOD1FOLH1FNTA | |
| SCHEMBL28720707 | 0.89 | NOD1 (0.67) | PTGS1GSTK1NOD1FOLH1SLC6A5 | |
| SCHEMBL929863 | 0.88 | PTGS1 (0.67) | PTGS1GSTK1NOD1FOLH1FNTA | |
| SCHEMBL12867529 | 0.88 | PTGS1 (0.57) | PTGS1GSTK1NOD1FOLH1FNTA | |
| SCHEMBL12867548 | 0.88 | PTGS1 (0.57) | PTGS1GSTK1NOD1FOLH1FNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2421883-A1 | TRAPPING COMPOUNDS AND METHOD FOR IDENTIFYING REACTIVE METABOLITES | Eisai R&D Management Co., Ltd. (JP) | 2012-02-29 | — | — | EP | disclosed |
| US-20120028284-A1 | TRAPPING COMPOUNDS AND METHOD FOR IDENTIFYING REACTIVE METABOLITES | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20120028284-A1 | TRAPPING COMPOUNDS AND METHOD FOR IDENTIFYING REACTIVE METABOLITES | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2012-02-02 | — | — | US | disclosed |
| WO-2010123085-A1 | TRAPPING COMPOUNDS AND METHOD FOR IDENTIFYING REACTIVE METABOLITES | EISAI R & D MANAGEMENT CO., LTD. (JP) | 2010-10-28 | — | — | WO | disclosed |
| WO-2010122673-A1 | TRAPPING COMPOUNDS AND METHOD FOR IDENTIFYING REACTIVE METABOLITES | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2010-10-28 | — | — | WO | disclosed |
| WO-2010123085-A1 | TRAPPING COMPOUNDS AND METHOD FOR IDENTIFYING REACTIVE METABOLITES | EISAI R & D MANAGEMENT CO., LTD. (JP) | 2010-10-28 | — | — | WO | disclosed |
| WO-2010122673-A1 | TRAPPING COMPOUNDS AND METHOD FOR IDENTIFYING REACTIVE METABOLITES | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2010-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120028284-A1 | TRAPPING COMPOUNDS AND METHOD FOR IDENTIFYING REACTIVE METABOLITES | CYP11B1, CYP11B2, CYP1A1 | PTGS1 268/4885GSTK1 109/4885NOD1 692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.